Form 4 for MAIA MAIA Biotechnology, Inc.
Accepted 2022-09-13 00:00:00 ET · period of report 2022-09-13 · accession 0001127602-22-022401 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-13 | 2022-09-13 | MAIA | Guerrero Ramiro | Dir | P - Purchase | $3.85 | +8,799 | 297.5K | +3% | +$33.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-13 | P | A | 8,798.73 | $3.85 | 297,464.04 | D | — | — | (F1) These shares were purchased by the reporting person in the open market for $3.85 per share on September 13, 2022. |